Don’t be duped by deceptive drugstore doubles
You can save a ton of money buying the “house brands” instead of the more expensive brand name beauty products right? The answer is, it depends. You need to really look at the label to make sure the ingredients match. Just because the so-called “generic” brand has a similar name, similar claims and similar packaging doesn’t automatically mean it has the same ingredients.
For example, take a look at Studio 35 Beauty’s version of Olay’s Regenerist Micro Sculpting cream.
Compare names
Regenerist Micro Sculpting cream vs Regenerating Daily Micro-shaping Cream
Compare claims
“Lifts and sculpts for young...
Source: thebeautybrains.com - February 27, 2014 Category: Consumer Health News Authors: Perry Romanowski Tags: Best Claims Source Type: blogs
Does niacinamide have to be used with resveratrol?
Lindygirl asks…In a recent facebook post from futurederm I read this : “Believe it or not, we now know you should always use niacinamide with resveratrol. Niacinamide has many benefits, but has been shown to increase sirtuin production, which may accelerate aging. On the other hand, resveratrol has been shown to decrease sirtuin production. So get the benefits of niacinamide without the sirtuins by using it together with resveratrol.” Olay also makes Regenerist Daily Regenerating Serum, Fragrance Free. That product contains niacinamide as well, but no resveratrol. So is using it for daytime a bad idea?
The Beaut...
Source: thebeautybrains.com - July 30, 2013 Category: Consumer Health News Authors: thebeautybrains Tags: Questions Source Type: blogs
Olay Regenerist Night Recovery Moisturizing Treatment: Look at the label
Olay Regenerist Night Recovery Moisturizing Treatment is a best selling beauty product on Amazon.com. It supposedly “doubles skin’s surface cell regeneration rate vs. untreated skin.” Is this too good to be true? Let’s look at the label to find out.
As with many P&G products, this is a complex formula with almost 50 different ingredients. Most of them form the cream base others are just for show. But the product does contains a number of good moisturizing agents (mostly silicone derivatives) and one “magic” ingredient: Niacinamide.
Niacinamide (aka nicotinamide) is a type of vitamin ...
Source: thebeautybrains.com - July 20, 2013 Category: Consumer Health News Authors: thebeautybrains Tags: Questions Source Type: blogs
Phosphate Additives Promote Hardening of the Arteries
In this study subjects who were allowed to eat only the foods supplied by the researchers were, for four weeks, fed a control diet free of any phosphate additives. Then, for the next four weeks, they were fed a diet that contained the identical amount of calories, protein, fat, and carbohydrate as the control diet but this diet was made up of foods containing inorganic phosphate additives, like American cheese, soda, and processed meats.The report explains, "The average phosphorus content of the daily menu was 979 mg during the control period and 2124 mg during the test period." After a month of eating the foods with the a...
Source: Diabetes Update - June 7, 2013 Category: Diabetes Authors: Jenny Source Type: blogs
Aveeno versus Clear: Which is better for your scalp?
Steve F says…I have dermatitis and my dermatologist advised me to use an anti-dandruff shampoo. I like both Aveeno Nourish + Dandruff Control and Clear Complete Care, but I’m wondering which is really better for my scalp. The ingredient lists seem quite different, with Clear’s containing a lot more oil and things I can pronounce. But does this really mean it’s better for me?
The Beauty Brains respond:
Let’s review the ingredients in each product to see if one is better for your scalp than the other.
Active drug ingredient
This is a little confusing because the Clear website doesn’t clear...
Source: thebeautybrains.com - May 29, 2013 Category: Consumer Health News Authors: thebeautybrains Tags: Questions Source Type: blogs
How Much?! AbbVie Raises Niaspan Price Despite Study Failures
Over the past two years, two studies showed the Niaspan cholesterol drug did not benefit patients. Yet AbbVie has managed to maintain revenue generated by the pill using a simple business proposition – the drugmaker has consistently raised its price, Bloomberg News writes. And the tactic is drawing criticism at a time of rising health care costs and ongoing debate over prescription drug prices.
The Abbott Laboratories now charges $4.78 per pill, up from $3.50 two years ago, a 37 percent increase. “I don’t know how you can justify it,” Robert Giugliano, a cardiologist at Brigham and Women’s Hospital in Boston a...
Source: Pharmalot - May 24, 2013 Category: Pharma Commentators Authors: esilverman Source Type: blogs
Self-Managing Cholesterol
By David Spero
As a recent study indicates, reducing LDL (“bad" cholesterol) can help prevent complications in most people with diabetes. Why is LDL cholesterol a bad thing, and how do you get to a healthy level?
First, what is cholesterol? Discovered in 1769 by analyzing gallstones, cholesterol is a fat-like organic chemical that is an essential part of animal cell membranes. Without it, cells won't function properly.
Cholesterol is made into bile, which is needed for digesting fats. It is also helps produce the body's natural steroids, including our sex hormones and the vital stress hormone cortisol. Cholesterol ...
Source: Diabetes Self-Management - May 15, 2013 Category: Diabetes Authors: David Spero Source Type: blogs
LaseResults Calm and Restore cream: How can I find a cheaper version?
Sugarcaned says…I fell in love with LaseResults® Calm & Restore Serum during a testing from a magazine that I participated in. I would love to find out what is in it that works so well to soothe my face and make it look absolutely amazing and feel baby soft. (Hopefully in a lower-priced product) I have extremely sensitive, combination skin with acne scars. I’m under 30.
The Beauty Brains respond:
Sure, go ahead and rub it in that you’re under 30. *Sigh* But just to be nice we’ll answer your question anyway!
What makes LaseResults work so well?
As you can see from the complete ingredient list ...
Source: thebeautybrains.com - May 2, 2013 Category: Consumer Health News Authors: thebeautybrains Tags: Questions Source Type: blogs
#182: ACC 2013: Stopping rivaroxaban and warfarin temporarily in AF patients yields similar risks; PREVAIL yanked from ACC program; Watchman device meets safety end point; Niacin full results in HPS2-THRIVE; Another strike for digoxin in AF
ACC 2013: Stopping rivaroxaban and warfarin temporarily in AF patients yields similar risks; PREVAIL yanked from ACC program; Watchman device meets safety end point; Niacin full results in HPS2-THRIVE; Another strike for digoxin in AF (Source: Blogs@theHeart.org)
Source: Blogs@theHeart.org - March 13, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: blogs
Niacin
The results the HPS2-THRIVE trial were presented at the ACC the other day. In this large trial, niacin was shown NOT to prevent major adverse Cardiovascular events any more than placebo. This is despite causing average reductions in LDL of 10 mg/dL and triglycerides of 33 mg/dL, in addition to a 6 mg/dL increase in HDL.
When interpreting a trial like this, it is important to understand the patient population studied. These were patients at high risk that already had LDL < 70mg/dL. This is important to understand. In patients like this, it is clear that niacin does not work. But what about patients who are on statin wi...
Source: Dr Portnay - March 11, 2013 Category: Cardiology Authors: Dr Portnay Source Type: blogs
HPS2-THRIVE: A ‘Disappointing But Clear’ Result
The results of HPS2-THRIVE were “disappointing but clear,” said Jane Armitage, who presented the results this morning at the ACC in San Francisco. HPS2-THRIVE randomized 25,673 high-risk patients who could tolerate niacin to either placebo or extended-release niacin plus laropiprant (Tredaptive, Merck), an anti-flushing agent, in addition to background therapy. The primary endpoint was the time to first major vascular event, defined as the composite of non-fatal MI or coronary death, any stroke or any arterial revascularization. Major vascular events occurred in 13.2% of the niacin arm and 13.7% of the plac...
Source: CardioBrief - March 9, 2013 Category: Cardiology Authors: Larry Husten Tags: People, Places & Events Prevention, Epidemiology & Outcomes High-density lipoprotein HPS2-THRIVE LDL Low-density lipoprotein niacin Source Type: blogs
Niacin
theheart.org is reporting today that The European Medicines Agency (EMA) will be launching a review of all niacin (nicotinic acid) agents. This is due to new data from a soon to be reported trial at the ACC in San Francisco, HPS2-THRIVE. It is being reported that a combination of niacin and another agent (which was supposed to reduce the flushing of niacin) "failed to show that the combination reduces the risk of major vascular events (such as heart attack and stroke), and a higher frequency of non-fatal but serious side effects was seen in patients taking the combination." The EMA is launching the review t...
Source: Dr Portnay - March 8, 2013 Category: Cardiology Authors: Dr Portnay Source Type: blogs
The "Buzz" on ACC.13 Late-Breaking Clinical Trials
This post is authored by Christopher P. Cannon, MD, FACC, is editor-in-chief of CardioSource Science and Quality.
Late-breaking clinical trials (LBCTs) have become the centerpiece of major cardiology scientific sessions. On the upside, they produce significant advances that will reshape the practice of medicine (if and when we ever adopt them), and, more recently, they’ve challenged long-held beliefs about the benefits of various older treatments. On the other hand, they can sometimes lead to disappointment (ie. when a study produces negative findings or is too small to be definitive).
So, LBCTs—are th...
Source: ACC in Touch Blog - March 6, 2013 Category: Cardiology Authors: Administrator Tags: ACC Scientific Session Science Source Type: blogs
#180: "Choosing wisely" now targets over 130 dubious tests, therapies; HPS2-THRIVE: High myopathy risk with niacin/laropiprant; unrestricted Mediterranean diets beat low-fat advice for primary CVD prevention; large proportion of raised LDL cholesterol...
Choosing wisely now targets over 130 dubious tests, therapies; HPS2-THRIVE: High myopathy risk with niacin/laropiprant; unrestricted Mediterranean diets beat low-fat advice for primary CVD prevention; large proportion of raised LDL cholesterol in (Source: Blogs@theHeart.org)
Source: Blogs@theHeart.org - March 1, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: blogs
Top stories in health and medicine, February 28, 2013
This series is brought to you by MedPage Today.1. 5 Psych Disorders Have Common Genetics. Autism, attention deficit-hyperactivity disorder (ADHD), bipolar disorder, major depressive disorder, and schizophrenia share common genetic underpinnings — despite differences in symptoms and course of disease.2. Imaging Suggests Wide Window for Alzheimer’s Tx. The biological path to Alzheimer’s disease might continue for more than a decade, suggesting a broad window of opportunity for intervention.3. Side Effects Dim Niacin Promise. A highly significant increase in adverse events, in particular myopathy, appears to...
Source: Kevin, M.D. - Medical Weblog - February 28, 2013 Category: Family Physicians Tags: News Heart Neurology Psychiatry Source Type: blogs
